The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

(Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved an update to the labeled strength of TWIRLA® ...

More than 65 percent of women ages 15 to 49 in the United States use some form of birth control, and many of them are on hormonal birth control methods like the pill, patch, ring, implant, injections, ...

WASHINGTON, Jan 18 (Reuters) - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U ...

Twirla (levonorgestrel/ethinyl estradiol) is a brand-name drug that’s prescribed for birth control. Twirla comes as a patch that’s applied to the skin once every 7 days for 3 consecutive weeks. Twirla ...

Shorter-acting birth control options must be maintained on a more regular basis, from daily to tri-monthly. The birth control patch (norelgestromin/ethinyl estradiol) must be applied weekly. Options ...